Founder effect of a pathogenic TNNT2 variant in the northwest of Spain responsible for a non-severe phenotype of hypertrophic cardiomyopathy.

Back

ESC Professional Premium Access

Founder effect of a pathogenic TNNT2 variant in the northwest of Spain responsible for a non-severe phenotype of hypertrophic cardiomyopathy.

Session: Hypertrophic cardiomyopathy: genotypes and phenotypes

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Valverde (Coruna, A, ES)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Maria Valverde

Health in Code, Coruna, A (Spain)

0 follower

6 more presentations in this session

The Australian Genetic Heart Disease Registry: Insights into healthcare utilisation and outcomes for genetic heart disease

Speaker: Ms A. Butters (Sydney, AU)

Family screening in hypertrophic cardiomyopathy - clinical and genetic yield at baseline

Speaker: Doctor E. Silajdzija (Copenhagen, DK)

Clinical significance and genetic basis of hypertrophic cardiomyopathy with apical phenotype: comparison of pure-apical form and distal-dominant form

Speaker: Doctor K. Sugiura (Nankoku, JP)

Epigenetic study of the differential phenotypic expression of a hypertrophic cardiomyopathy-related pathological variant at MYBPC3 in a cohort of monozygotic twins

Speaker: Mr A. Penarroya (Oviedo, ES)

A novel strategy for key gene identification in hypertrophic cardiomyopathy based on cuproptosis and multiple WGCNA analyses

Speaker: Doctor Y. Xiao (Changsha, CN)

Access

Abstract

Slides

Access the full session

Hypertrophic cardiomyopathy: genotypes and phenotypes

Speakers: Doctor M. Valverde, Ms A. Butters, Doctor E. Silajdzija, Doctor K. Sugiura, Mr A. Penarroya...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Founder effect of a pathogenic TNNT2 variant in the northwest of Spain responsible for a non-severe phenotype of hypertrophic cardiomyopathy.

About the speaker

Doctor Maria Valverde

6 more presentations in this session

The Australian Genetic Heart Disease Registry: Insights into healthcare utilisation and outcomes for genetic heart disease

Family screening in hypertrophic cardiomyopathy - clinical and genetic yield at baseline

Clinical significance and genetic basis of hypertrophic cardiomyopathy with apical phenotype: comparison of pure-apical form and distal-dominant form

Epigenetic study of the differential phenotypic expression of a hypertrophic cardiomyopathy-related pathological variant at MYBPC3 in a cohort of monozygotic twins

A novel strategy for key gene identification in hypertrophic cardiomyopathy based on cuproptosis and multiple WGCNA analyses

Access the full session

Hypertrophic cardiomyopathy: genotypes and phenotypes

About the event

ESC Congress 2023

ESC 365 is supported by